OOIR: Observatory of International Research

Papers

(The median citation count of HIV Medicine is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-01-01 to 2025-01-01.)

Article	Citations
Issue Information	69
Hepatitis delta in HIV/hepatitis B coinfection: A call for action	69
Nutrition counselling and clinical outcomes in HIV: A systematic review and meta‐analysis	62
Areas with high HIV prevalence: A spatial analysis of nationwide claims data in Germany	61
Implementation of frailty screening for older people living with HIV in Brighton, UK	48
Participation, retention and uptake in a multicentre pre‐exposure prophylaxis cohort using online, smartphone‐compatible data collection	39
	35
Comparing effectiveness of first‐line antiretroviral therapy between peri‐urban and rural clinics in KwaZulu‐Natal, South Africa	32
Positive Outcomes: Validity, reliability and responsiveness of a novel person‐centred outcome measure for people with HIV	28
The British HIV Association national clinical audit 2021: Management of HIV and hepatitis C coinfection	27
Tobacco smoking and binge alcohol use are associated with incident venous thromboembolism in an HIV cohort	27
	25
Mapping frailty in people living with HIV: A nationwide study in Greece	24
	24
	23
Issue Information	23
Poster Abstracts	22
Issue Information	22
Issue Information	21
Potentially inappropriate prescriptions and potential prescription omissions in older people living with HIV	20
Prevalence of, risk factors for, and target organ damage from metabolic syndrome among people living with HIV on ART: A cross‐sectional analysis in Chongqing, China	18
The propositive study: Immunogenicity and safety of a four‐component recombinant protein‐based vaccine against MenB and a quadrivalent conjugate MenACWY vaccine in people living	16
Potential drug–drug interactions between antiretroviral drugs and comedications, including dietary supplements, among people living with HIV: A clinical survey	16
	15
Effect of HIV infection on pre‐ and post‐liver transplant mortality in patients with organ failure	15

Weight changes, metabolic syndrome and all‐cause mortality among Asian adults living with HIV	15
Disparities in HIV continuum of care in the paediatric population: A real‐life study in Brazil	15
Snapshot of clinical problems among people living with HIV in China	15
	15
	15
Issue Information	14
HIV cure: Are we going to make history?	14
Estimating the hospital costs of care for people living with HIV in England using routinely collected data	13
Subclinical atherosclerosis as detected by carotid ultrasound and associations with cardiac and HIV‐specific risk factors; the Archi‐Prevaleat project	13
Trend over time of HIV‐1 drug resistance to nonnucleoside reverse transcriptase inhibitors (NNRTIs) and their drivers: A cohort study from Antiviral Response Cohort Analysis (	12
Issue Information	12
The shifting picture of HIV treatment, comorbidity and substance use among US MSM living with HIV	12
	12
Prevalence of osteoporosis in people living with HIV and risk factors associated in the cART era	11
Issue Information	11
British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of pulmonary opportunistic infections 2024	11
Characteristics of HIV post‐exposure prophylaxis recipients at six English sexual health clinics during COVID‐19	10
The use of non‐invasive imaging modalities for the assessment of skeletal muscle quantity and quality in people with HIV: A narrative review	10
	10
Tackling ageism in the healthcare system: A community perspective	10
Effectiveness of intensive adherence counselling in achieving an undetectable viral load among people on antiretroviral therapy with low‐level viraemia in Uganda	10
	10
	10
Daily ritonavir‐boosted darunavir for viral suppression in pregnancy (DRV‐P)	9
Issue Information	9
HIV outcomes during the COVID‐19 pandemic in people of Black ethnicities living with HIV in England	9
Perception of PrEP‐related stigma in PrEP users: Results from the ANRS‐PREVENIR cohort	9
Quality of life among people living with HIV aged 50 years and over in Australia: Identifying opportunities to support better ageing	9
‘We want it all’:ARTpreferences assessed byDesirability ofOutcomeRanking	9
Reflections on a specialist HIV menopause service	9
Issue Information	9
Poster Abstracts	9
Public understanding and awareness of and response to monkeypox virus outbreak: A cross‐sectional survey of the most affected communities in the United Kingdom during the 2022 public health emergency	9
Assessment of weight gain in adult patients living with HIV receiving first‐line dolutegravir‐based or efavirenz‐based ART regimens in routine care clinics in Tshwane district, S	9
Who is lost to follow‐up in HIV care? Assessment of care retention over time and the impact of COVID‐19. Longitudinal analysis of the PISCIS cohort	9
Estimating the risk of mortality attributable to recent late HIV diagnosis following admission to the intensive care unit: A single‐centre observational cohort study	8
Disparities in healthcare access and utilization among people living with HIV in China: A scoping review and meta‐analysis	8
The association between use of chemsex drugs and HIV clinic attendance among gay and bisexual men living with HIV in London	8
Pilot evaluation of PrEP EmERGE – A novel digital health innovation designed to support sexual health clinics and HIV‐PrEP users	8
HIV medicine editorial: Opt‐out HIV testing in the UK: Approaching the endgame?	8
Characterizing heart failure and its subtypes in people living with HIV	8
Effectiveness of integrase strand transfer inhibitors in HIV‐infected treatment‐experienced individuals across Europe	8
Differences in hypertension and prehypertension among people living with and without HIV in China: role of HIV infection and antiretroviral therapy	8
British HIV Association guidelines for the management of HIV‐2 2021	8
The characteristics of men who have sex with men (MSM) using post‐exposure prophylaxis for sexual exposure (PEPSE) in the pre‐exposure prophylaxis (PrEP) era	8
The prevalence of major depressive disorder in people with HIV: Results from the All of Us Research Program	7
SARS‐CoV‐2 vaccine immunogenicity for people living with HIV: A systematic review and meta‐analysis	7
Cardiovascular medication adherence testing in patients living with HIV: A single‐centre observational study	7
Associations between HIV, antiretroviral therapy and preterm birth in the US Women’s Interagency HIV Study, 1995–2018: a prospective cohort	7
Sex differences in the effectiveness and tolerability of dolutegravir plus rilpivirine as a switch strategy in people living with HIV	7

The data‐collection on adverse effects of anti‐HIV drugs (D:A:D) model for predicting cardiovascular events: External validation in a diverse cohort of people living with HIV	7
Intergenerational sex and early sexual debut are associated with HIV infection among transgender women in Paraguay	7
Telemedicine in HIV health care during the COVID‐19 pandemic: An implementation research study in Buenos Aires, Argentina	7
Issue Information	7
Early HIV viral suppression associated with subsequent 12‐month treatment success among people living with HIV in South Africa	7
Long‐acting injectable cabotegravir forPrEP: A game‐changer inHIVprevention?	7
A qualitative study of the impact of coronavirus disease (COVID‐19) on psychological and financial wellbeing and engagement in care among men who have sex with men living with HIV in Thailand	7
Prevalence of people living with multidrug‐resistant HIV and limited treatment options in Spain	7
Fostemsavir and ethinyl estradiol drug interaction: Clinical recommendations for co‐administration	7
Experiences with health care services and HIV testing after sexual assault in cisgender gay, bisexual and other men who have sex with men and transgender people	7
Post‐partum contraception in women living with HIV	7
Dolutegravir in real life: Self‐reported mental and physical health outcomes after transitioning from efavirenz‐ to dolutegravir‐based antiretroviral therapy in a prospective cohort study in Lesotho	7
Facilitators and barriers of women's participation in HIV clinical research in Switzerland: A qualitative study	7
Weight gain following the single substitution of tenofovir disoproxil fumarate by tenofovir alafenamide in HIV‐infected people from the French Dat'AIDS cohort: A propensity score	7
Treatment‐emergent reverse transcriptase resistance during antiretroviral therapy with bictegravir, tenofovir alafenamide, and emtricitabine: A case series	6
Commentary on ‘Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI‐net)’	6
Menopausal status, age and management among women living with HIV in the UK	6
Late diagnosis of HIV infection in Warsaw: Estimating the scale of the problem and demographic trends	6
IgG seroprevalence of COVID‐19 among people living with HIV or at high risk of HIV in south‐west Germany: A seroprevalence study	6
High mortality among patients hospitalized for drug‐resistant tuberculosis with acquired second‐line drug resistance and high HIV prevalence	6
Delayed HIV diagnosis during the COVID‐19 pandemic in Poland: A call for targeted HIV testing for those under suspicion of SARS‐CoV‐2	6
Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI‐net)	6
Association of low‐level viremia with mortality among people living with HIV on antiretroviral therapy in Dehong, Southwest China: A retrospective cohort study	6
Effect of an opt‐out point‐of‐care HIV‐1 nucleic acid testing intervention to detect acute and prevalent HIV infection in symptomatic adult outpatients and reduce HIV transmission in Kenya: a randomiz	6
Comorbidities and co‐medications among 28 089 people living with HIV: A nationwide cohort study from 2009 to 2019 in Japan	6
Sleep deficiency among people living with human immunodeficiency virus: A growing challenge	6
CROI 2024 BHIVA working group summary	6
Prevalence of anal high‐risk human papillomavirus (HR‐HPV) types in people living with HIV and a history of cancer	6
Perspectives of people with HIV and HIV clinicians on characteristics of antiretroviral treatment and HIV‐related symptoms	6
Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in Germany	6
Comorbidities in women living with HIV: A systematic review	6
Changing co‐morbidity and increasing deprivation among people living with HIV: UK population‐based cross‐sectional study	5
Missed opportunities for HIV pre‐exposure prophylaxis among people with recent HIV infection: The French ANRS 95041 OMaPrEP study	5
Sero‐negative HIV, a need for presumptive HIV diagnosis in adults in developing countries	5
EACS Abstracts	5
Author Index	5
Issue Information	5
Prevalence of mental health conditions among people living with HIV during the COVID‐19 pandemic: A rapid systematic review and meta‐analysis	5
External validation of the Dat'AIDS score: A risk score for predicting 5‐year overall mortality in people living with HIV aged 60 years or older	5
Longitudinal analysis of new‐onset non‐AIDS‐defining diseases among people living with HIV: A real‐world observational study	5
Framingham risk score based vascular outcomes in acute versus chronic HIV cohorts after 6 years of ART	5
Long COVID among people with HIV: A systematic review and meta‐analysis	5
An audit of HIV testing practice in people aged 50 years and over presenting with a known clinical indicator condition in secondary care	5
Tolerability of four‐drug antiretroviral combination therapy in primary HIV‐1 infection	5
Loneliness and social isolation in people with HIV aged ≥50 years. The No One Alone (NOA)‐GeSIDA study conducted by the GeSIDA 12021 study group	5
Related barriers to using HIV pre‐exposure prophylaxis among MSM: A multicentre cross‐sectional survey	5
Issue Information	5
Immune reconstitution inflammatory syndrome‐associated Graves disease in HIV‐infected patients: clinical characteristics and response to radioactive iodine therapy	5
Children living with HIV in Europe: do migrants have worse treatment outcomes?	5
	5
Issue Information	5
Themed Poster Abstracts	5
Issue Information	5
Qualitative assessment of anti‐SARS‐CoV‐2 spike protein immunogenicity (QUASI) after COVID‐19 vaccination in older people living with HIV	5
Issue Information	5
A qualitative study of perspectives, experiences and priority outcomes for people living with HIV and frailty	5
Clinical characteristics of women with HIV in the RESPOND cohort: A descriptive analysis and comparison to men	5
The first AI‐based Chatbot to promote HIV self‐management: A mixed methods usability study	5
Prediction of future cardiovascular events by Framingham, SCORE and asCVD risk scores is less accurate in HIV‐positive individuals from the HIV‐HEART Study compared with the general population	5
	5
Use of contraindicated antiretroviral drugs in people with HIV/HCV coinfections receiving HCV treatment with direct‐acting antivirals—Results from the EuroSIDA	5
Clinical and laboratory impact of concomitant syphilis infection during acute HIV	4
	4
Impact of social determinants of health on time to antiretroviral therapy initiation and HIV viral undetectability for migrants enrolled in a multidisciplinary HIV clinic with rapid, free, and onsite	4
Letter to the editor	4
Clinical outcomes of patients with and without HIV hospitalized with COVID‐19 in England during the early stages of the pandemic: a matched retrospective multi‐centre analysis (RECEDE‐C19 study)	4
Predictors of knowledge of and access to biomedical prevention among MSM and transgender men in Latin America: Results from the Latin American internet survey	4
	4
Issue Information	4
Issue Information	4
HIV treatment cascade in regions of Peru with the highest HIV prevalence	4
Are there additional adverse effects of testosterone use among men living with HIV?—Data from the PUSH! study	4
HIV‐associated plasmablastic lymphoma: A single‐centre 12‐year experience in Kwa‐Zulu Natal, South Africa	4
Integrase strand transfer inhibitor treatment does not increase the incidence of immune reconstitution inflammatory syndrome in HIV‐infected Koreans	4
Mimicking measles and syphilis: Mpox in PLHIV	4
How are HIV services in the UK currently identifying and managing patients with cognitive impairment? Results of a national survey	4
Evaluating the effect of atorvastatin exposure and vitamin D levels on lipid outcomes in people with HIV‐1 with suppressed HIV‐1 RNA and LDL cholesterol <	4
The use of tenofovir in patients with COVID‐19	4
Incidence of sexually transmitted infections and association with behavioural factors: Time‐to‐event analysis of a large pre‐exposure prophylaxis (PrEP) cohort	4
Issue Information	4

	4
Therapeutic failure reported with HIV long‐acting injectables: An analysis of the FDA Adverse Event Reporting System from 2021 to 2024	4
	4
Issue Information	4
Markers of ovarian reserve in women living with HIV: A systematic review	3
Chemsex and its impact on gay and bisexual men who have sex with men: Findings from an online survey in Belgium	3
Editorial comment on: Amphetamine‐related intoxications in people living with HIV: An observational study in an emergency department in Barcelona (Spain) from 2018 to 2020	3
Influence of physical activity on endothelial function in people living with HIV	3
Cerebrospinal fluid virology in people with HIV	3
Standardizing HIV post‐exposure prophylaxis in the emergency department following sexual assault	3
Comment on “A plague passing over: clinical features of the 2022 mpox outbreak in patients of colour living with HIV”	3
Hepatic steatosis in people older and younger than fifty who are living with HIV and HIV‐negative controls: A cross‐sectional study nested within the POPPY cohort	3
One for all, all for one: neuro‐HIV multidisciplinary platform for the assessment and management of neurocognitive complaints in people living with HIV	3
Medically assisted reproduction for people living with HIV in Europe: A cross‐country exploratory policy comparison	3
Efficacy of an electronic reminder for HIV screening in primary healthcare based on indicator conditions in Catalonia (Spain)	3
Assessment of targeted intervention programme under the National AIDS Control Program among men who have sex with men in India	3
Diagnostic value of serological biomarkers for detection of non‐alcoholic fatty liver disease (NAFLD) and/or advanced liver fibrosis in people living with HIV	3
Clinical outcomes of HIV–syphilis coinfection among patients with no neurological symptoms: a retrospective cohort study	3
HIV/AIDS post‐exposure prophylaxis knowledge and uptake among health professionals in Africa: Systematic review and meta‐analysis	3
Anal cytological abnormalities and human papillomavirus infection in women living with HIV: A systematic review and meta‐analysis	3
Development of the HIV360 international core set of outcome measures for adults living with HIV: A consensus process	3
Coverage of maternal viral load monitoring during pregnancy in South Africa: Results from the 2019 national Antenatal HIV Sentinel Survey	3
Why we need to re‐define long‐term success for people living with HIV	3
Frailty and sarcopenia among Turkish people aged 40 and above living with HIV	3
The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study	3
‘We are fragile, but we are strong’: A qualitative study of perspectives, experiences and priority outcomes for people living with HIV and frailty	3
Prognostic factors for competing risk in patients with AIDS‐related Kaposi's sarcoma: A SEER population‐based study	3
Pre‐treatment and acquired antiretroviral drug resistance among people living with HIV in Tianjin, China	3
Letter to the editor on “a matched cohort study investigating premature, accentuated, and accelerated aging in people living with HIV”	3
Prescribing patterns of antiretroviral treatments during pregnancy for women living with HIV in Canada 2004–2020: A surveillance study	3
Differences in integrated assessment and management of non‐communicable diseases (NCDs) for people with HIV across the WHO European region	3
FRAX assessment in people ageing with HIV	3
Obesity in women living with HIV aged 45–60 in England: An analysis of the PRIME study	3
Optimizing statin prescriptions for people living with HIV: Evidence for improved communication and shared care between primary care and specialist HIV services	3
Compassionate use of long‐acting cabotegravir plus rilpivirine for people living with HIV‐1 in need of parenteral antiretroviral therapy	3
Splenomegaly is a marker of advanced chronic liver disease and portal hypertension in HIV infection	3
Re‐valuation of annual cytology using HPV self‐sampling to upgrade prevention (REACH UP): A feasibility study in women living with HIV in the UK	3
	3
Associations between HIV infection and frailty status and its individual components: Are frailty components disproportionally affected?	3
Current practice and recommendations for management of hepatitis B virus in people living with HIV in Asia	3
Exploring implementation considerations forgeriatric‐HIVclinics: A secondary analysis from a scoping review onHIVmodels of geriatric care	3
A matched cohort study investigating premature, accentuated, and accelerated aging in people living with HIV	3
Trends of age‐related non‐communicable diseases in people living with HIV and comparison with uninfected controls: A nationwide population‐based study in South Korea	3
Relapse of neurosymptomatic cerebrospinal fluid HIV RNA escape	3
The National Evaluation of Malawi’s PMTCT Program (NEMAPP) study: 24‐month HIV‐exposed infant outcomes from a prospective cohort study	3
Poster Abstracts	3
COVID‐19 hospitalization outcomes in adults by HIV status; a nation‐wide register‐based study	3
	3
Efficacy and safety of dolutegravir/rilpivirine in real‐world clinical practice. GeSIDA study 1119	3
	3
The value of herpes zoster prevention in people aging with HIV: A narrative review	3
Immune response to mRNA‐based COVID‐19 booster vaccination in people living with HIV	3
Patient‐reported outcome measures in adult HIV care: A rapid scoping review of targeted outcomes and instruments used	3
Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real‐world setting in Belgium	3
Issue Information	2
Evaluation of archived drug resistance mutations in HIV‐1 DNA among vertically infected adolescents under antiretroviral treatment in Cameroon: Findings during the COVID	2
High prevalence of osteoporosis among virally suppressed older people (≥60 years) living with HIV	2
	2
“It's like it's the old boys club”—the age‐related experiences of diverse older women living with HIV: A scoping review and consultative exercise	2
Rising mortality among people who inject drugs living with HIV in Scotland, UK: A 20‐year retrospective cohort study	2
Long‐term outcomes for children and adolescents with Kaposi sarcoma	2
DORA: 48‐week weight and metabolic changes in Black women with HIV, in a phase IIIb switch study from dolutegravir‐ or efavirenz‐ to doravirine‐based first‐line antiretroviral th	2
Issue Information	2
The effect of HIV and mpox co‐infection on clinical outcomes: Systematic review and meta‐analysis	2
	2
Trends in preterm birth in women living with HIV in Switzerland over the last three decades: A multicentric, prospective, cohort study	2
Cardiovascular disease risk in people of African ancestry with HIV in the United Kingdom	2
No overall impact on body mass index for age change after dolutegravir initiation in a French paediatric cohort	2
	2
Issue Information	2
Voluntary counselling and testing points (VCTs) in Poland as a complementary and accessible alternative to public healthcare facilities: A comparative analysis of epidemiological data from	2
Cardiovascular prevention: Statins and beyond–A message from the editors of the special issue of HIV medicine	2
Clinical HIV outcome trajectories associated with a history of child protective service out‐of‐home care: Longitudinal cohort findings with women living with HIV in Canada	2
Late Breaker Abstracts	2
Issue Information	2
No increased risk of tuberculosis‐related immune reconstitution inflammatory syndrome with integrase inhibitor‐based antiretroviral therapy in people withHIV with profound immunosuppression	2
	2
Mpox in people with HIV: A narrative review	2
Cost of non‐communicable diseases in people living with HIV in the Central Denmark Region	2
Improvement in insulin sensitivity after switching from an integrase inhibitor‐based regimen to doravirine/tenofovir disoproxil fumarate/lamivudine in people with significant weight gain	2
No overall impact on rate of weight gain with integrase inhibitor‐containing regimens in antiretroviral‐naïve adults	2
Evaluation of HIV antiretroviral treatment adherence in 2019 using anonymized data from the French national health insurance claims data base: The COCOVIH study	2
Issue Information	2
Serum globulin levels are associated with HIV reservoir size and immune restoration during long‐term ART	2
Access to care and impact on HIV treatment interruptions during the COVID‐19 pandemic among people living with HIV in British Columbia	2
Issue Information	2
Same‐day antiretroviral therapy initiation for people living with HIV who have tuberculosis symptoms: a systematic review	2
Impact of hormonal therapy on HIV‐1 immune markers in cis women and gender minorities	2
Covid‐19 First Wave Impact National Survey for HIV Clinicians by Public Health England (PHE), the British HIV Association (BHIVA) and the Children’s HIV Association (CHIVA)	2
Impact of the COVID‐19 pandemic on the HIV care continuum and associated factors in middle‐income countries: A mixed‐methods systematic review	2
Author Index	2
	2
Issue Information	2
Exploring the cascade of mental healthcare among people with HIV experiencing depressive symptoms in the UK and Ireland: The POPPY study	2
Statin gap in patients living with HIV: assessing dose appropriateness	2